Clinical Trials on Malignant Hematologic Neoplasm

Total 113576 results

Sanofi

Completed

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Neoplasm Malignant

Spain, Belgium, United States, France
NatureWise Biotech & Medicals Corporation

Completed

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer

Malignant Neoplasm

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer

Malignant Neoplasm

United States
Gary Morrow
National Cancer Institute (NCI)

Completed

Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials

Malignant Neoplasm

United States
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Pharmaceutical Research Associates

Unknown

A Study of PSB205 in Subjects With Advanced Solid Tumors

Neoplasm Malignant

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Conquer Cancer Foundation

Completed

Resistance Training Program and Cardiovascular Exercise in Increasing Muscle Mass in Adolescent and Young Adult Stem Cell Transplant Survivors

Malignant Neoplasm

United States
Jonsson Comprehensive Cancer Center

Terminated

18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions

Malignant Neoplasm

United States
Li Yu

Unknown

Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Malignant Neoplasm

China
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant

Malignant Neoplasm

United States
Sanofi
Merck KGaA, Darmstadt, Germany

Completed

A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients

Neoplasm Malignant

Netherlands, France
Sanofi

Completed

Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients (SARMETA)

Neoplasm Malignant

Korea, Republic of, Japan
Sanofi
Regeneron Pharmaceuticals

Completed

A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies

Neoplasm Malignant

China
Sanofi

Completed

Effect of SAR302503 on ECG Activity in Patients With Solid Tumors

Neoplasm Malignant

Belgium, United States
Sanofi
Regeneron Pharmaceuticals

Completed

A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors

Neoplasm Malignant

China
National Cancer Institute (NCI)

Terminated

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Nodular Malignant Melanoma | Solar Radiation-related Skin Melanoma | Superficial Spreading Malignant Melanoma

United States
Children's Cancer Group, China
Shanghai Pudong District Center for Disease Control and Prevention

Recruiting

Vaccination for Children of H&O and Their Parents

Hematologic Malignancy | Solid Tumor, Childhood | Vaccination

China
Community Cancer Care
Amgen

Unknown

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Cancer | Solid Tumor | Hematologic Malignancy

United States
Sameek Roychowdhury

Active, not recruiting

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

Cholangiocarcinoma | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

Hematopoietic and Lymphoid Cell Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm

United States, Canada
University of Oklahoma

Completed

Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice (PalliaQOL)

Hematologic Malignancy

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Solid Tumor | Hematologic Malignancy | Solid Tumor, Adult | Solid Carcinoma

United States
Tyligand Bioscience (Shanghai) Limited

Recruiting

TSN084 Treating Patients With Advanced Malignant Tumors

Malignant Neoplasm

China
Guangzhou First People's Hospital

Recruiting

An Observational Clinical Study Plan on the Effects of Radiotherapy on the Immune System of Patients With Malignant Tumors.

Malignant Neoplasm

China
Wuhan Union Hospital, China

Recruiting

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Malignant Neoplasm

China
Imperial College London

Recruiting

iKnife REIMS Project (iKnife)

Neoplasms | Neoplasm Malignant

United Kingdom
University of Southern California
National Cancer Institute (NCI)

Recruiting

18F-FMAU PET/CT in Imaging Patients With Advanced Cancers

Malignant Neoplasm

United States
The Second Hospital of Lanzhou University

Completed

Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection

Malignant Neoplasm

China
Sameek Roychowdhury

Active, not recruiting

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

Malignant Neoplasm

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy

Malignant Neoplasm

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Perioperative Ostomy Self-Management Telehealth for Cancer Patients and Family Caregivers

Malignant Neoplasm

United States
University Hospital, Essen

Completed

FAPI PET/CT Prospective Interobserver Agreement (AGREE-FAPI)

Malignant Neoplasm

Germany
Lawson Health Research Institute
London Health Sciences Centre

Completed

Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study

Malignant Neoplasm

Canada
Vanderbilt-Ingram Cancer Center

Terminated

Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

Malignant Neoplasm

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Local Anesthetic Cream in Younger Patients Undergoing Lumbar Punctures

Malignant Neoplasm

United States
Sanofi

Completed

A Study of SAR428926 in Patients With Advanced Solid Tumors

Neoplasm Malignant

France, Denmark, Spain
Sanofi

Completed

Phase 1 Safety Testing of SAR405838

Neoplasm Malignant

United States, France, Netherlands
National Cancer Institute (NCI)

Completed

Evaluation of Food Effect on Pharmacokinetics of Vismodegib

Malignant Neoplasm

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients

Malignant Neoplasm

United States
Sanofi

Completed

Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors

Neoplasm Malignant

Japan
Sanofi

Completed

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

Neoplasm Malignant

United States
Ohio State University Comprehensive Cancer Center

Completed

Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)

Malignant Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy

Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm

United States
European Institute of Oncology

Recruiting

Evaluation of a Music and Interaction Intervention on Patient Distress During Whole Body Magnetic Resonance

Neoplasm Malignant

Italy
Biotheus Inc.

Recruiting

PM8002 in the Treatment of Patients With Advanced Solid Tumors

Malignant Neoplasm

China
Wuhan Union Hospital, China

Recruiting

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

Malignant Neoplasm

China
Pennington Biomedical Research Center

Recruiting

A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer (Small Steps)

Neoplasm Malignant

United States
University of Southern California
National Cancer Institute (NCI)

Recruiting

Movement and Fitness Trackers in Determining Performance Status

Malignant Neoplasm

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Malignant Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families

Malignant Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment

Malignant Neoplasm

United States

Clinical Trials on Malignant Hematologic Neoplasm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations